Get started
Author

Rebecca M. Olson

Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation
2019 · Amina A. Negash, Rebecca M. Olson, et al. · PLoS Pathogens · 107
PDF
Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831
2014 · Nadine Norton, Rebecca M. Olson, et al. · Cancer Immunology Research · 48
PDF
2,3,4,5-Tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT2C agonists
2003 · Michael D Ennis, Robert L Hoffman, et al. · Bioorganic & Medicinal Chemistry Letters · 36
Identification of the Factors That Govern the Ability of Therapeutic Antibodies to Provide Postchallenge Protection Against Botulinum Toxin: A Model for Assessing Postchallenge Efficacy of Medical Countermeasures against Agents of Bioterrorism and Biological Warfare
2011 · Fetweh H. Al-Saleem, Zidoon Nasser, et al. · Journal of Pharmacology and Experimental Therapeutics · 22
PDF
Evidence That Botulinum Toxin Receptors on Epithelial Cells and Neuronal Cells Are Not Identical: Implications for Development of a Non-Neurotropic Vaccine
2010 · Md. Elias, Fetweh al-Saleem, et al. · Journal of Pharmacology and Experimental Therapeutics · 21
PDF
Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge
2011 · Waleed Mustafa, Fetweh H. Al-Saleem, et al. · Vaccine · 20
BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations
2017 · Jeffrey M. Duggan, Matthew B. Buechler, et al. · Blood · 9
Innate immune regulation in HIV latency models
2022 · Rebecca M. Olson, Germán Gornalusse, et al. · Retrovirology · 6
PDF
Abstract 3916: Inhibition of GREB1 mRNA and protein limits ER+ breast tumor cell proliferation
2012 · H. James Hnatyszyn, Rebecca Olson, et al. · Cancer Research · 1
Data from Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831
2023 · Nadine Norton, Rebecca M. Olson, et al.
Data Supplement from Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831
2023 · Nadine Norton, Rebecca M. Olson, et al.
Data Supplement from Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831
2023 · Nadine Norton, Rebecca M. Olson, et al.
Data from Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831
2023 · Nadine Norton, Rebecca M. Olson, et al.
Additional file 2 of Innate immune regulation in HIV latency models
2022 · Olson, Rebecca M., Gornalusse, Germán, et al. · Figshare
Additional file 3 of Innate immune regulation in HIV latency models
2022 · Olson, Rebecca M., Gornalusse, Germán, et al. · Figshare
Abstract B123: Analysis of the associations of FC gamma receptor polymorphisms (FCGR3A, FCGR2A, and FCGR2B) with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) trial N9831
2013 · Mark Pegram, Rebecca M. Olson, et al. · Molecular Cancer Research
P5-01-15: The Functional Role of the Estrogen-Regulated Gene GREB1: Characterization of a Novel GREB1 Knockout Mouse Model.
2011 · HJ Hnatyszyn, C Rodriguez, et al. · Cancer Research
Works count: 23
Citation count: 270
H-index: 7
I10-index: 6
Year
Topic
Type